In March, Health Recovery Solutions published a blog post on the potential of telehealth to disrupt the current system of treatment for those living with end-stage renal disease (ESRD). The post highlighted several aspects of ESRD treatment, including: the cost of treatment to Medicare and other payor agencies, the preference of patients and families to receive treatment at home, and the need to increase engagement between patients and clinicians. Today, we revisit the utilization of telehealth to treat ESRD patients in the wake of recent CMS reimbursement changes.
